Know Labs is changing how to analyze and monitor molecules non-invasively. Its proprietary technology platform uses radio-frequency spectroscopy and can be integrated into various wearable, mobile, or bench-top form factors. Know Labs’ first application is a blood glucose monitoring medical device that will provide the user with real-time information on their glucose levels, assisting people with diabetes and pre-diabetes to manage their medical condition. Know Labs is a small business based in Seattle – USA, and a public company whose shares trade under the stock symbol “KNW” (NYSE American).